Share this post on:

Acarbose

Acarbose is an anti-diabetic α-glucosidase inhibitor that decreases digestion of complex carbohydrates and prevents glucose absorption. Acarbose improves insulin sensitivity and decreases postprandial hyperglycemia.

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18835555

Cas No.

56180-94-0

Purity

≥98%

Formula

C25H43NO18

Formula Wt.

645.6

Chemical Name

O-4,6-Dideoxy-4-[[[1S-(1α,4α,5-β,6α))-4,5,6- trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-α-D-glucopyranosyl-(1-4)-O-α-D-glucopyranosyl-(1-4)-D-glucose

IUPAC Name

(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol

Synonym

Bay g 5421; Glucobay; Prandase; Precose

Melting Point

90°C

Solubility

Soluble in water (129mg/mL), methanol, ethanol (8mg/mL), and DMSO (129mg/mL)

Appearance

White to off white powder

Kalra S. Alpha glucosidase inhibitors. J Pak Med Assoc. 2014 Apr;64(4):474-6. PMID: 24864650.

Okada K, Yanagawa T, Warabi E, et al. The alpha-glucosidase inhibitor acarbose prevents obesity and simple steatosis in sequestosome 1/A170/p62 deficient mice. Hepatol Res. 2009 May;39(5):490-500. PMID: 19207582.

Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study. Am J Med. 1997 Dec;103(6):483-90. PMID: 9428831.

SP2509